Vaccine against autoimmune disease: Antigen-specific immunotherapy

Robert P. Anderson, Bana Jabri

Research output: Contribution to journalReview articlepeer-review

63 Scopus citations


Recent interest in testing whether the success of antigen-specific immunotherapy (ASIT) for autoimmune diseases in mice can be translated to humans has highlighted the need for better tools to study and understand human autoimmunity. Clinical development of ASIT for allergy has been instructive, but limited understanding of CD4 T cell epitope/determinant hierarchies hampers the rational design and monitoring of ASIT. Definitive identification of pathogenic T cell epitopes as is now known in celiac disease and recent initiatives to optimize immune monitoring will facilitate rational design, monitoring and mechanistic understanding of ASIT for human autoimmune diseases.

Original languageEnglish
Pages (from-to)410-417
Number of pages8
JournalCurrent Opinion in Immunology
Issue number3
StatePublished - Jun 2013
Externally publishedYes


Dive into the research topics of 'Vaccine against autoimmune disease: Antigen-specific immunotherapy'. Together they form a unique fingerprint.

Cite this